About
Cohance Lifesciences Limited engages in the contract research, development, and manufacturing of new chemical entity (NCE) based intermediates, active pharmaceutical ingredients (API), specialty chemicals, and formulated drugs in India, the United States, Europe, and internationally. The company offers small molecule APIs, advanced intermediates, and starting materials; antibody drug conjugates; high-purity oligonucleotide building blocks comprising phosphoramidites, nucleosides, pseudouridine, NTPs, CAP reagents, GalNAc conjugates, and fluorescent dyes; pellets and finished dosage forms; and specialty chemicals, including agrochemicals. It serves pharmaceutical, biotechnology, and chemical companies. The company was formerly known as Suven Pharmaceuticals Limited and changed its name to Cohance Lifesciences Limited in May 2025. The company was founded in 1989 and is headquartered in Hyderabad, India. Cohance Lifesciences Limited is a subsidiary of Berhyanda Limited.
Key Metrics
as of Sep 2026Market Cap17,469 Cr
P/E162.00
Div Yield0.00 %
Book Value₹102.00
52w High₹1,039.00
52w Low₹267.00
Face Value₹1.00
Quarterly Results
Rs. Crores · hover row for definition| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 359.89 | 567.55 | 481.58 | 497.79 | 483.58 | 768.57 | 653.35 | 594.43 | 488.08 | 252.93 | 212.82 | 224.62 | 344.03 |
| Expenses | 333.40 | 450.98 | 378.80 | 366.93 | 379.38 | 545.80 | 420.60 | 390.91 | 362.91 | 179.60 | 143.76 | 127.27 | 174.15 |
| Operating Profit | 26.49 | 116.57 | 102.78 | 130.86 | 104.20 | 222.77 | 232.75 | 203.52 | 125.17 | 73.33 | 69.06 | 97.35 | 169.88 |
| OPM % | 7.36 | 20.54 | 21.34 | 26.29 | 21.55 | 28.98 | 35.62 | 34.24 | 25.65 | 28.99 | 32.45 | 43.34 | 49.38 |
| Other Income | 12.16 | -17.30 | 1.26 | 26.30 | 5.00 | -7.59 | 21.48 | 15.76 | 19.41 | 17.06 | 13.97 | 14.20 | 10.06 |
| Depreciation | 34.32 | 37.66 | 33.36 | 31.20 | 31.36 | 42.58 | 38.09 | 34.56 | 31.28 | 17.25 | 11.38 | 10.48 | 11.15 |
| Interest | 2.12 | 5.17 | 5.25 | 5.24 | 6.80 | 7.00 | 10.08 | 9.42 | 10.20 | 2.30 | 2.15 | 0.50 | 1.15 |
| Profit before tax | 2.21 | 56.44 | 65.43 | 120.72 | 71.04 | 165.60 | 206.06 | 175.30 | 103.10 | 70.84 | 69.50 | 100.57 | 167.64 |
| Tax % | 36.20 | 38.77 | 27.72 | 21.89 | 26.00 | 25.86 | 25.33 | 20.65 | 26.82 | 24.87 | 24.66 | 25.69 | 25.86 |
| Net Profit | 1.41 | 34.56 | 47.29 | 94.29 | 52.57 | 122.77 | 153.86 | 139.10 | 75.45 | 53.22 | 52.36 | 74.73 | 124.29 |
| EPS in Rs | 0.04 | 0.90 | 1.24 | 2.46 | 1.37 | 4.82 | 6.04 | 5.46 | 2.96 | 2.09 | 2.06 | 2.94 | 4.88 |
Profit & Loss
Annual · Rs. Crores| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|---|---|---|---|
| Sales | 2,030.00 | 2,504.00 | 1,051.00 | 1,330.00 | 1,320.00 | 1,010.00 | 834.00 | 378.00 |
| Expenses | 1,576.00 | 1,720.00 | 645.00 | 739.00 | 738.00 | 567.00 | 449.00 | 206.00 |
| Operating Profit | 454.00 | 784.00 | 406.00 | 591.00 | 582.00 | 443.00 | 385.00 | 172.00 |
| OPM % | 22.00 | 31.00 | 39.00 | 44.00 | 44.00 | 44.00 | 46.00 | 45.00 |
| Other Income | 15.00 | 49.00 | 57.00 | 45.00 | 188.00 | 14.00 | 18.00 | 1.00 |
| Interest | 22.00 | 37.00 | 7.00 | 13.00 | 9.00 | 12.00 | 22.00 | 3.00 |
| Depreciation | 134.00 | 147.00 | 55.00 | 43.00 | 39.00 | 32.00 | 24.00 | 12.00 |
| Profit before tax | 314.00 | 650.00 | 400.00 | 579.00 | 722.00 | 414.00 | 358.00 | 158.00 |
| Tax % | 27.00 | 24.00 | 26.00 | 25.00 | 23.00 | 25.00 | 24.00 | 31.00 |
| Net Profit | 229.00 | 491.00 | 296.00 | 433.00 | 558.00 | 309.00 | 270.00 | 109.00 |
| EPS in Rs | 5.98 | 19.29 | 11.65 | 16.99 | 21.92 | 12.12 | 10.61 | — |
| Dividend Payout % | 0.00 | 0.00 | 0.00 | 35.00 | 23.00 | 16.00 | 24.00 | 0.00 |
Balance Sheet
Annual · Rs. Crores — latest first| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 38.00 | 25.00 | 25.00 | 25.00 | 25.00 | 25.00 | 13.00 | 0.00 |
| Reserves | 4,442.00 | 4,242.00 | 2,003.00 | 1,724.00 | 1,495.00 | 1,040.00 | 770.00 | 578.00 |
| Borrowings | 146.00 | 306.00 | 65.00 | 70.00 | 97.00 | 143.00 | 186.00 | 83.00 |
| Other Liabilities | 487.00 | 464.00 | 121.00 | 139.00 | 187.00 | 151.00 | 142.00 | 123.00 |
| Total Liabilities | 5,113.00 | 5,037.00 | 2,214.00 | 1,958.00 | 1,805.00 | 1,359.00 | 1,111.00 | 783.00 |
| Fixed Assets | 2,288.00 | 2,079.00 | 670.00 | 512.00 | 534.00 | 441.00 | 357.00 | 271.00 |
| CWIP | 146.00 | 333.00 | 179.00 | 165.00 | 30.00 | 96.00 | 102.00 | 111.00 |
| Investments | 1,187.00 | 1,117.00 | 893.00 | 710.00 | 600.00 | 426.00 | 276.00 | 7.00 |
| Other Assets | 1,493.00 | 1,509.00 | 473.00 | 571.00 | 641.00 | 395.00 | 376.00 | 394.00 |
| Total Assets | 5,113.00 | 5,037.00 | 2,214.00 | 1,958.00 | 1,805.00 | 1,359.00 | 1,111.00 | 783.00 |
Cash Flows
Annual · Rs. Crores — latest first| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 390.00 | 686.00 | 376.00 | 493.00 | 270.00 | 330.00 | 359.00 | 50.00 |
| Cash from Investing Activity | -204.00 | -455.00 | -362.00 | -237.00 | -90.00 | -258.00 | -367.00 | -65.00 |
| Cash from Financing Activity | -203.00 | -310.00 | -40.00 | -243.00 | -156.00 | -77.00 | 9.00 | 26.00 |
| Net Cash Flow | -18.00 | -79.00 | -26.00 | 13.00 | 23.00 | -4.00 | 1.00 | 11.00 |
| Free Cash Flow | 237.00 | 386.00 | 324.00 | 348.00 | 195.00 | 219.00 | 256.00 | -6.00 |
| CFO/OP % | 100.00 | 110.00 | 119.00 | 108.00 | 72.00 | 99.00 | 116.00 | 49.00 |
Ratios
Annual · Days / % — latest first| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 |
|---|---|---|---|---|---|---|---|---|
| Debtor Days | 115.00 | 106.00 | 46.00 | 30.00 | 65.00 | 37.00 | 51.00 | 142.00 |
| Inventory Days | 302.00 | 205.00 | 268.00 | 284.00 | 259.00 | 243.00 | 278.00 | 556.00 |
| Days Payable | 145.00 | 117.00 | 49.00 | 61.00 | 97.00 | 100.00 | 113.00 | 190.00 |
| Cash Conversion Cycle | 272.00 | 195.00 | 265.00 | 253.00 | 228.00 | 180.00 | 217.00 | 509.00 |
| Working Capital Days | 159.00 | 121.00 | 108.00 | 99.00 | 107.00 | 56.00 | 64.00 | 205.00 |
| ROCE % | 8.00 | 21.00 | 21.00 | 34.00 | 50.00 | 39.00 | 46.00 | — |
Corporate Actions
11 records| Action | Ex Date | Record Date | Ratio | Amount (₹) | Notes |
|---|---|---|---|---|---|
| Other | 06 Aug 2024 | — | — | — | Annual General Meeting |
| Other | 12 Dec 2023 | — | — | — | Annual General Meeting |
| Dividend | 09 Sep 2022 | 12 Sep 2022 | — | 5.00 | NSE/BSE dividend mismatch: BSE/NSE=1.0; BSE/NSE=5.0 |
| Dividend | 09 Sep 2022 | 12 Sep 2022 | — | 1.00 | NSE/BSE dividend mismatch: BSE/NSE=1.0; BSE/NSE=5.0 |
| Other | 11 Aug 2022 | — | — | — | Annual General Meeting |
| Dividend | 13 May 2022 | 17 May 2022 | — | 1.00 | |
| Dividend | 15 Feb 2022 | 16 Feb 2022 | — | 2.00 | NSE/BSE dividend mismatch: BSE/NSE=1.0; BSE/NSE=2.0 |
| Dividend | 15 Feb 2022 | 16 Feb 2022 | — | 1.00 | NSE/BSE dividend mismatch: BSE/NSE=1.0; BSE/NSE=2.0 |
| Dividend | 13 Aug 2021 | 17 Aug 2021 | — | 1.00 | |
| Dividend | 17 Feb 2021 | 18 Feb 2021 | — | 1.00 | |
| Bonus | 25 Sep 2020 | 28 Sep 2020 | 1:1 | — |
Announcements
5 filingsShareholding Pattern
Open on BSEFinancial Results — Filings
Open on BSEBoard Filings
Open on BSEAnnual Reports
Credit Ratings
-
Rating update12 Aug from crisil
-
Rating update5 Aug from crisil
-
Rating update3 Dec 2025 from fitch
-
Rating update26 Aug 2025 from crisil
-
Rating update23 Jul 2025 from care
-
Rating update28 May 2025 from crisil
Conference Calls
- PPT
- PPT
- PPT
- PPT
- PPT
- PPT
- PPT
- PPT
- PPT
- PPT
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript
- Transcript